Gainers
-
VeriFone Systems, Inc. (NYSE: PAY) climbed 51.87
percent to close at $22.78 after the payment and commerce solutions company agreed to sell itself. VeriFone agreed to be
acquired by Francisco Partners, a technology-focused private equity firm for $23.04 per share, or $3.4 billion which includes
Verifone's net debt.
-
Kingtone Wirelessinfo Solution Holding Ltd (NASDAQ: KONE) shares surged 45.51 percent to close at $7.45 on Tuesday.
-
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
shares rose 41.9 percent to close at $20.76. Spectrum Pharmaceuticals reported update of MD Anderson’s Phase 2 Data studying
poziotinib in EGFR Exon 20 Mutant Non-Small Cell Lung Cancer patients.
-
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares
gained 22.55 percent to close at $7.01 after the company reported preliminary results for its first quarter.
-
Ossen Innovation Co., Ltd. (NASDAQ: OSN) shares
rose 19.07 percent to close at $2.56.
-
REGENXBIO Inc. (NASDAQ: RGNX) shares surged 18.92
percent to close at $37.40.
-
SemiLEDs Corporation (NASDAQ: LEDS) gained 18.13
percent to close at $4.30 on Tuesday.
-
Vuzix Corporation (NASDAQ: VUZI) rose 17.59
percent to close at $6.35 as the company disclosed that its M300 smart glasses has been selected by Oracle as a part of service
cloud showcase at the ModernCX.
-
Sprint Corporation (NYSE: S) shares jumped 17.12
percent to close at $6.02. Just five months after T-Mobile US and Sprint abandoned merger talks, the two are back at the table
in preliminary discussions, according to the Wall Street Journal.
-
resTORbio, Inc. (NASDAQ: TORC) gained 16.81
percent to close at $9.38.
-
ShiftPixy, Inc. (NASDAQ: PIXY) shares rose 15.98
percent to close at $3.12.
-
Cronos Group Inc. (NASDAQ: CRON) shares gained
14.36 percent to close at $6.37.
-
MACOM Technology Solutions Holdings, Inc. (NASDAQ: MTSI) jumped 14.29 percent to close at $18.32. MACOM introduced MATA-07825, a
new Transimpedance Amplifier (TIA) for supporting 12G-SDI transmission over optical fiber.
-
Neuralstem, Inc. (NASDAQ: CUR) climbed 13.77
percent to close at $1.90 after the biopharmaceutical company that focuses on nervous system therapies based on stem cell
technology said it completed part of a phase 1 study. Neuralstem completed its first surgery in the second cervical injury
cohort of a phase 1 clinical trial in patients with chronic spinal cord injury with its lead stem cell therapy candidate,
NSI-566.
-
Adesto Technologies Corporation (NASDAQ: IOTS)
rose 13.51 percent to close at $8.40.
-
California Resources Corporation (NYSE: CRC) shares
jumped 13.34 percent to close at $20.47 on Tuesday.
-
Profire Energy, Inc. (NASDAQ: PFIE) shares rose
13.17 percent to close at $3.18.
-
KemPharm, Inc. (NASDAQ: KMPH) shares surged 12.93
percent to close at $6.55.
-
ViewRay, Inc. (NASDAQ: VRAY) shares gained 11.25
percent to close at $7.12.
-
Energous Corporation (NASDAQ: WATT) rose 9.97
percent to close at $18.31. The maker of wire-free charging technologies said it received a certification for its WattUp Near
Field transmitter from the Federal Communications Commission.
-
Karyopharm Therapeutics Inc (NASDAQ: KPTI) rose
6.33 percent to close at $12.76. The clinical-stage pharmaceutical company announced the FDA granted a Fast Track designation
for its oral Selective Inhibitor of Nuclear Export (SINE) compound selinexor that is used for the treatment of patients with
multiple myeloma.
-
NVIDIA Corporation (NASDAQ: NVDA) rose 5.8
percent to close at $227.91. Morgan Stanley upgraded NVIDIA from Equal-Weight to Overweight.
-
Seagate Technology plc (NASDAQ: STX) rose 5.44
percent to close at $59.35. Morgan Stanley upgraded Seagate from Equal-Weight to Overweight.
Losers
-
vTv Therapeutics Inc. (NASDAQ: VTVT) shares
dipped 78.1 percent to close at $0.7144. vTv Therapeutics announced Monday after the close that results from Part A of its
late-stage study of an investigational medication to treat Alzheimer's disease did not meet either co-primary endpoint.
-
New Age Beverages Corporation (NASDAQ: NBEV)
dropped 16.35 percent to close at $1.74 after announcing a common stock offering.
-
Selecta Biosciences, Inc. (NASDAQ: SELB) shares
fell 15.22 percent to close at $9.36. Selecta Biosciences presented new data from ongoing Phase 2 trial of SEL-212.
-
Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) shares
fell 14.48 percent to close at $3.07.
-
Marrone Bio Innovations, Inc. (NASDAQ: MBII)
dropped 11.83 percent to close at $2.31.
-
Ultra Petroleum Corp. (NYSE: UPL) shares fell 11.65
percent to close at $3.11.
-
Tupperware Brands Corporation (NYSE: TUP) declined
11.49 percent to close at $41.74 after the company lowered its earnings forecast for the first quarter.
-
Therapix Biosciences Ltd. (NASDAQ: TRPX) shares
fell 11.31 percent to close at $5.33.
-
EMCORE Corporation (NASDAQ: EMKR) declined 10.71
percent to close at $5.00 as the company lowered its Q2 sales guidance.
-
Helios and Matheson Analytics Inc. (NASDAQ: HMNY)
shares dropped 8.04 percent to close at $2.86.
-
Envision Healthcare Corporation (NYSE: EVHC) shares
dipped 7.34 percent to close at $35.83.
-
ARMO BioSciences, Inc. (NASDAQ: ARMO) shares
dropped 6.91 percent to close at $32.07.
-
Restoration Robotics, Inc. (NASDAQ: HAIR) fell
6.61 percent to close at $4.80.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.